CAS: 1365287-97-3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Emibetuzumab REF: TM-T76743CAS: 1365287-97-3 | SDS-PAGE:96.2%;SEC-HPLC:98.8% | 144.00 €~677.00 € | Mon 14 Apr 25 |
 | Emibetuzumab REF: 3D-CLA1359CAS: 1365287-97-3 | - - - | To inquire | Thu 24 Apr 25 |
Emibetuzumab
CAS:1365287-97-3
Emibetuzumab: potent humanized MET antibody, antitumor, inhibits HGF/MET pathways, for advanced prostate cancer research.
Purity:
SDS-PAGE:96.2%;SEC-HPLC:98.8%
Color and Shape:
Liquid
Molecular weight:
143.74 kDa
Ref: TM-T76743
| 1mg | 144.00 € | ||
| 5mg | 424.00 € | ||
| 10mg | 677.00 € |
Estimated delivery in United States, on Monday 14 Apr 2025
Ref: 3D-CLA1359
| Undefined size | To inquire |
Estimated delivery in United States, on Thursday 24 Apr 2025
